Vicor Technologies, Inc., Information
Vicor Technologies, Inc. is a medical diagnostic company developing breakthrough risk stratification technology for several indications, including Sudden Cardiac Death (SCD). Vicor has developed a medical device, the PD2i Cardiac Analyzer, which uses a patented, proprietary analysis to accurately identify patients as high or low risk of SCD within a six month time frame. This can lead to a high level of patient care, minimization of medical expenses, and enhancement of the patient's Quality of Life. Vicor expects to soon file for U.S. FDA device approval based upon a large-scale clinical trial, the VITAL Trial currently being conducted and coordinated by the Harvard Clinical Research Institute (HCRI; a Harvard University affiliate), and Target Health, Inc. For more information, please CLICK HERE .